FTIH to Evaluate Safety, Tolerability, and Pharmacokinetics of Single Oral Doses of GSK1322888 in Healthy Caucasian and Japanese Volunteers
Clinical trial NCT01294566 · COMPLETED
Trial details
- NCT number
- NCT01294566
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-11-29
- Primary completion
- 2011-03-23
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.